Michael Atkins
Förmögenhet: 6 489 $ per 2026-05-31
Förmögenhet: 6 489 $ per 2026-05-31
Michael B. Atkins currently holds the positions of Director at Melanoma Research Foundation, Independent Director at Werewolf Therapeutics, Inc. since 2024, President at Society For Immunotherapy of Cancer, and Professor at Harvard Medical School since 2002.
Dr. Atkins completed undergraduate education at Tufts University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-12 | 14 419 ( 0,03 % ) | 6 489 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-01-04 |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Direktör/Styrelseledamot | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2002-01-01 |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Commercial Services |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån